Citric Acid Cycle Explained: The Krebs Cycle in Mitochondria

The citric acid cycle is regulated through three main mechanisms: (1) controlling pyruvate decarboxylation to regulate acetyl-CoA entry, and (2) regulating two key allosteric enzymes—Isocitrate dehydrogenase (step 3) and Alpha-ketoglutarate dehydrogenase (step 4)—where ADP activates these enzymes to increase cycle rate when ATP is low, while ATP, NADH, and succinyl-CoA inhibit them to decrease cycle rate when energy is abundant.

NADH allosterically inhibits all three key enzymes because accumulating NADH signals the cycle is producing more electron carriers than the electron transport chain can consume. ATP inhibits citrate synthase and isocitrate dehydrogenase but not alpha-ketoglutarate dehydrogenase. Citrate negatively feeds back on citrate synthase, while succinyl-CoA inhibits both alpha-ketoglutarate dehydrogenase and citrate synthase. ADP serves as an allosteric activator, signaling low cellular energy status by activating citrate synthase and isocitrate dehydrogenase. Calcium acts as an allosteric activator in muscle cells, coupling muscle contraction with increased ATP production by activating isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase.

The citric acid cycle is regulated at three key points through allosteric and feedback mechanisms. Citrate synthase is inhibited by ATP and NADH, activated by ADP. Isocitrate dehydrogenase is inhibited by NADH, activated by ADP. Alpha-ketoglutarate dehydrogenase is inhibited by succinyl-CoA (feedback) and by NADH/ATP (allosteric). The cycle functions to generate reduced coenzymes, oxidize fuel molecules, and provide biosynthetic intermediates. It does not produce acetyl-CoA, which is the input entering the cycle.

The citric acid cycle is regulated through multiple mechanisms to match metabolic demand with supply. Allosteric regulation involves small molecules binding to enzymes to modulate activity—high-energy signals like ATP and NADH inhibit the pathway, while low-energy signals like AMP and ADP activate it. Covalent regulation through phosphorylation adds another layer of control, particularly for pyruvate dehydrogenase. Key regulatory enzymes include pyruvate dehydrogenase (converting pyruvate to acetyl-CoA), citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase complex. These enzymes are inhibited by their own products (feedback inhibition) and respond to calcium levels reflecting electron transport chain function.

The citric acid cycle is regulated through multiple mechanisms: allosteric modulation by ATP, ADP, NADH, and calcium; feedback inhibition of key enzymes; and covalent phosphorylation of pyruvate dehydrogenase. Pyruvate dehydrogenase responds to acetyl-CoA, fatty acids, NADH, and phosphorylation states. High energy status inhibits the cycle, while low energy activates it. These regulatory layers ensure metabolic adaptation to cellular conditions.

The TCA cycle is amphibolic, meaning it serves both catabolic (breakdown) and anabolic (synthesis) functions. While it primarily functions in energy production, its intermediates are used as precursors for biosynthesis. Oxaloacetate and alpha-ketoglutarate are precursors for amino acids (glutamate, aspartate). Succinyl-CoA is used for heme and chlorophyll synthesis. Citrate is used for fatty acid synthesis. Aspartate is used for alkaloids and purine synthesis. This dual function makes the TCA cycle a central metabolic pathway that connects energy production with biosynthesis.

The TCA (Krebs/Citric Acid) cycle is amphibolic because it serves dual metabolic functions: catabolically, it oxidizes acetyl-CoA to produce energy (ATP, NADH, FADH2), while anabolically, its intermediates serve as precursors for biosynthesis (amino acids, nucleotides, heme, and other molecules). This dual role allows the cycle to both generate energy and provide building blocks for cellular components, making it central to metabolism.

The citric acid cycle (TCA cycle) is called amphibolic because it performs both catabolic (breaking down acetyl-CoA to CO2 for energy production) and anabolic (providing intermediates for biosynthesis of carbohydrates, amino acids, lipids, purines, pyrimidines, and heme) functions; cataplerotic reactions involve intermediates exiting the cycle for biosynthesis, while anaplerotic reactions replenish these intermediates through pathways like pyruvate carboxylation and reversible transamination from amino acids.

Cellular respiration consists of three stages: (1) Production of Acetyl-CoA from glucose, amino acids, and fatty acids; (2) Oxidation of Acetyl-CoA in the TCA cycle producing NADH and FADH2; (3) Electron transfer and oxidative phosphorylation generating ATP. The TCA cycle occurs in the mitochondrial matrix and serves three functions: oxidation of acetyl-CoA to CO2, production of NADH and FADH2, and generation of biosynthetic precursors. The cycle consists of eight enzymatic reactions: citrate synthase, aconitase, isocitrate dehydrogenase, alpha-ketoglutarate dehydrogenase, succinyl-CoA synthetase, succinate dehydrogenase, fumarase, and malate dehydrogenase. One complete turn produces three NADH, one FADH2, and one GTP/ATP. Complete glucose oxidation yields 30-32 ATP. The cycle is amphibolic, with intermediates drained for biosynthesis (citrate for fatty acids, alpha-ketoglutarate for amino acids, succinyl-CoA for heme, oxaloacetate for gluconeogenesis). Anaplerotic reactions replenish intermediates: pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and malate dehydrogenase. The cycle is regulated at three irreversible steps: citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase.

The TCA cycle is called amphibolic because it serves dual metabolic roles: catabolism (breaking down acetyl-CoA to release energy as ATP) and anabolism (providing intermediates for synthesizing heme, cholesterol, steroids, glucose, fatty acids, and non-essential amino acids). This dual functionality distinguishes it as a central metabolic pathway that connects energy production with biosynthesis.

Single enzyme deficiencies in the Krebs cycle can lead to serious diseases. Alpha-ketoglutarate dehydrogenase mutations producing NADPH-dependent activity generate 2-hydroxyglutarate, which inhibits histone demethylases and causes glioblastoma multiforme. Succinate dehydrogenase mutations cause pheochromocytoma, tumors of the adrenal medulla producing excessive catecholamines. Fumarase deficiency leads to fumarate accumulation and development of leiomyomas (benign smooth muscle tumors) in uterine and kidney tissues. These examples demonstrate how metabolic enzyme dysfunction disrupts cellular homeostasis and contributes to oncogenesis.

Deficiencies of Krebs cycle enzymes are associated with various diseases. Aconitase deficiency is associated with optic atrophy. Isocitrate dehydrogenase deficiency is associated with glioblastoma and acute myeloid leukemia. Succinate dehydrogenase deficiency is associated with paragangliomas and gastrointestinal stromal tumors. Fumarase deficiency is associated with encephalopathy and leiomyomatosis. These associations demonstrate how metabolic enzyme deficiencies can lead to specific pathological conditions.

The Krebs cycle (Citric acid cycle/TCA cycle) is a central metabolic pathway that oxidizes acetyl-CoA derived from pyruvate to generate energy carriers (NADH, FADH2) and ATP, with key regulatory enzymes including citrate synthase (activated by ADP, inhibited by ATP/NADH/citrate), isocitrate dehydrogenase (activated by ADP/calcium, inhibited by ATP/NADH), and alpha-ketoglutarate dehydrogenase (similar to pyruvate dehydrogenase complex); enzyme deficiencies such as alpha-ketoglutarate dehydrogenase deficiency cause congenital lactic acidosis, while succinate dehydrogenase mutations are associated with pheochromocytoma and renal cell carcinoma.

Mutations in Krebs cycle enzymes (SDH, FH, IDH) reveal that metabolic enzymes function as tumor suppressors. Loss-of-function mutations cause accumulation of oncometabolites (succinate, fumarate, 2-hydroxyglutarate) that inhibit prolyl hydroxylases, stabilizing HIF-1α and creating pseudohypoxia even under normoxia. These oncometabolites also disrupt epigenetic regulation by competing with alpha-ketoglutarate for dioxygenase active sites, leading to widespread changes in gene expression that promote cancer development.

Genetic disorders affecting Krebs cycle enzymes can cause serious health problems. Deficiencies in enzymes like aconitase can lead to neurological damage due to reduced energy production and accumulation of toxic intermediates. The cycle requires coenzymes including NAD+, FAD, and coenzyme A as electron carriers. Fluoroacetate poisoning provides a natural example of cycle inhibition—when animals consume contaminated plants, fluoroacetate is converted to fluorocitrate, which irreversibly binds to aconitase and blocks the cycle. This demonstrates how the Krebs cycle can be targeted by natural toxins, leading to energy failure and death.